Top 5 stories on new drugs for HIV prevention and treatment from CROI 2023
Experimental islatravir implants protect monkeys against HIV-like virus
HIV infections acquired while on injectable PrEP may take a very long time to be spotted
Good news for women and PrEP: quarterly dosing may work
Cabotegravir long-acting PrEP out of reach for upper middle-income nations
Closure of HIV vaccine study shows how far we have to go
South Africa to begin piloting injectable PrEP in early 2023
Merck restarts islatravir HIV treatment studies, but abandons monthly PrEP
Injectable PrEP is just as effective for transgender women as it is for gay men, study analysis finds
